Your Cart ( 1 Item )
-
Long-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis
October 2022 | Volume 21 | Issue 10 | Case Reports | 1124 | Copyright © October 2022
Mohamed Abuzakouk MDa, Omar Ghorab MB Bch BAOb, Rajaie Namas MDc, Marcus Maurer MDd
You will have 48 hours to download the full-text PDFPrice
24.95
Total ( 1 Item ) $24.95 CHECKOUT